7e8fc4446a17ab0f23008c2161c996a7  285850.pdf
9b96b855ae670b3217d8a0fef9e0afb5f53d91d7  285850.pdf
ed77a8aa9edda1f567029f7b8eb4d7d323f0e8451f983bfafc04047a9d8db80b  285850.pdf

Title:          Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial
Subject:        Lancet Oncology, 20 (2019) 1023-1034. doi:10.1016/S1470-2045(19)30215-3
Keywords:       
Author:         Prof Ian Judson MD
Creator:        Elsevier
Producer:       Acrobat Distiller 6.0 for Windows
CreationDate:   Sat Jun 22 01:14:17 2019 CEST
ModDate:        Sat Jun 29 09:49:10 2019 CEST
Tagged:         no
UserProperties: no
Suspects:       no
Form:           none
JavaScript:     no
Pages:          12
Encrypted:      no
Page size:      595.276 x 799.37 pts
Page rot:       0
File size:      1358606 bytes
Optimized:      yes
PDF version:    1.7


name                                 type              encoding         emb sub uni object ID
------------------------------------ ----------------- ---------------- --- --- --- ---------
KDWPTH+Shaker2Lancet-Regular         Type 1C           Custom           yes yes yes     72  0
KDWPTH+Shaker2Lancet-Italic          Type 1C           WinAnsi          yes yes yes     73  0
OJKNXZ+Shaker2Lancet-Bold            Type 1C           Custom           yes yes yes     74  0
KDWPTH+ScalaLancetPro-Bold           Type 1C           Custom           yes yes yes     86  0
KDWPTH+Shaker2Lancet-BoldItalic      Type 1C           Custom           yes yes yes     92  0
KDWPTH+ScalaLancetPro                Type 1C           Custom           yes yes yes     98  0
OJKNXZ+Shaker2Lancet-Bold            Type 1C           WinAnsi          yes yes yes    112  0
KDWPTH+ScalaLancetPro-Italic         Type 1C           WinAnsi          yes yes yes     39  0
OJKNXZ+Shaker2Lancet-Bold            Type 1C           WinAnsi          yes yes yes     35  0
OJKNXZ+Shaker2Lancet-Bold            Type 1C           WinAnsi          yes yes yes     42  0
KDWPTH+Shaker2Lancet-Regular         Type 1C           WinAnsi          yes yes no      48  0
KDWPTH+Shaker2Lancet-Regular         Type 1C           WinAnsi          yes yes no      51  0
KDWPTH+Shaker2Lancet-Regular         Type 1C           WinAnsi          yes yes no      50  0
OJKNXZ+Shaker2Lancet-Bold            Type 1C           WinAnsi          yes yes no      52  0
KDWPTH+Shaker2Lancet-Regular         Type 1C           WinAnsi          yes yes no      54  0
OJKNXZ+Shaker2Lancet-Bold            Type 1C           WinAnsi          yes yes no      56  0
KDWPTH+Shaker2Lancet-Regular         Type 1C           WinAnsi          yes yes no      55  0


Jhove (Rel. 1.28.0, 2023-05-18)
 Date: 2023-12-14 02:37:09 CET
 RepresentationInformation: 285850.pdf
  ReportingModule: PDF-hul, Rel. 1.12.4 (2023-03-16)
  LastModified: 2023-12-13 13:49:51 CET
  Size: 1358606
  Format: PDF
  Version: 1.7
  Status: Well-Formed and valid
  SignatureMatches:
   PDF-hul
  MIMEtype: application/pdf
  Profile: Linearized PDF
  PDFMetadata: 
   Objects: 147
   FreeObjects: 1
   IncrementalUpdates: 1
   DocumentCatalog: 
    ViewerPreferences: 
     HideToolbar: false
     HideMenubar: false
     HideWindowUI: false
     FitWindow: false
     CenterWindow: false
     DisplayDocTitle: false
     NonFullScreenPageMode: UseNone
     Direction: L2R
     ViewArea: CropBox
     ViewClip: CropBox
     PrintArea: CropBox
     PageClip: CropBox
    PageLayout: SinglePage
    PageMode: UseOutlines
    Language: en-GB
    Outlines: 
     Item: 
      Title: Cediranib in patients with alveolar soft-part sarcoma
(CASPS): a double-blind, placebo-controlled, randomised,
phase 2 trial
      Children: 
       Item: 
        Title: Introduction
       Item: 
        Title: Methods
        Children: 
         Item: 
          Title: Study design and participants
         Item: 
          Title: Randomisation and masking
         Item: 
          Title: Procedures
         Item: 
          Title: Outcomes
         Item: 
          Title: Statistical analysis
         Item: 
          Title: Role of the funding sources
       Item: 
        Title: Results
       Item: 
        Title: Discussion
       Item: 
        Title: Acknowledgments
       Item: 
        Title: References
   Info: 
    Title: Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial
    Author: Prof Ian Judson MD
    Subject: Lancet Oncology, 20 (2019) 1023-1034. doi:10.1016/S1470-2045(19)30215-3
    Keywords: 
    Creator: Elsevier
    Producer: Acrobat Distiller 6.0 for Windows
    CreationDate: Sat Jun 22 01:44:17 CEST 2019
    ModDate: Sat Jun 29 10:19:10 CEST 2019
   ID: 0x571c9ae1dc6748c0acf9d531017246b6, 0x5d26e812a353d34bb64f96c305fddc18
   Filters: 
    FilterPipeline: FlateDecode
   Fonts: 
    Type1: 
     Font: 
      BaseFont: KDWPTH+ScalaLancetPro
      FontSubset: true
      FirstChar: 24
      LastChar: 246
      FontDescriptor: 
       FontName: KDWPTH+ScalaLancetPro
       Flags: Serif, Nonsymbolic
       FontBBox: -64, -271, 1200, 922
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: KDWPTH+ScalaLancetPro-Italic
      FontSubset: true
      FirstChar: 32
      LastChar: 150
      FontDescriptor: 
       FontName: KDWPTH+ScalaLancetPro-Italic
       Flags: Serif, Nonsymbolic
       FontBBox: -174, -271, 1200, 922
       FontFile3: true
      Encoding: WinAnsiEncoding
      ToUnicode: true
     Font: 
      BaseFont: KDWPTH+Shaker2Lancet-Regular
      FontSubset: true
      FirstChar: 27
      LastChar: 243
      FontDescriptor: 
       FontName: KDWPTH+Shaker2Lancet-Regular
       Flags: Nonsymbolic
       FontBBox: -158, -241, 1019, 980
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: KDWPTH+Shaker2Lancet-Italic
      FontSubset: true
      FirstChar: 32
      LastChar: 243
      FontDescriptor: 
       FontName: KDWPTH+Shaker2Lancet-Italic
       Flags: Nonsymbolic, Italic
       FontBBox: -177, -241, 960, 980
       FontFile3: true
      Encoding: WinAnsiEncoding
      ToUnicode: true
     Font: 
      BaseFont: OJKNXZ+Shaker2Lancet-Bold
      FontSubset: true
      FirstChar: 31
      LastChar: 150
      FontDescriptor: 
       FontName: OJKNXZ+Shaker2Lancet-Bold
       Flags: Nonsymbolic
       FontBBox: -164, -241, 1109, 981
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: KDWPTH+Shaker2Lancet-Regular
      FontSubset: true
      FirstChar: 32
      LastChar: 135
      FontDescriptor: 
       FontName: KDWPTH+Shaker2Lancet-Regular
       Flags: Nonsymbolic
       FontBBox: -158, -241, 1019, 980
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: KDWPTH+Shaker2Lancet-Regular
      FontSubset: true
      FirstChar: 32
      LastChar: 183
      FontDescriptor: 
       FontName: KDWPTH+Shaker2Lancet-Regular
       Flags: Nonsymbolic
       FontBBox: -158, -241, 1019, 980
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: KDWPTH+Shaker2Lancet-Regular
      FontSubset: true
      FirstChar: 32
      LastChar: 150
      FontDescriptor: 
       FontName: KDWPTH+Shaker2Lancet-Regular
       Flags: Nonsymbolic
       FontBBox: -158, -241, 1019, 980
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: OJKNXZ+Shaker2Lancet-Bold
      FontSubset: true
      FirstChar: 32
      LastChar: 117
      FontDescriptor: 
       FontName: OJKNXZ+Shaker2Lancet-Bold
       Flags: Nonsymbolic
       FontBBox: -164, -241, 1109, 981
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: KDWPTH+ScalaLancetPro-Bold
      FontSubset: true
      FirstChar: 28
      LastChar: 183
      FontDescriptor: 
       FontName: KDWPTH+ScalaLancetPro-Bold
       Flags: Serif, Nonsymbolic
       FontBBox: -62, -271, 1199, 922
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: KDWPTH+Shaker2Lancet-Regular
      FontSubset: true
      FirstChar: 32
      LastChar: 183
      FontDescriptor: 
       FontName: KDWPTH+Shaker2Lancet-Regular
       Flags: Nonsymbolic
       FontBBox: -158, -241, 1019, 980
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: KDWPTH+Shaker2Lancet-Regular
      FontSubset: true
      FirstChar: 32
      LastChar: 183
      FontDescriptor: 
       FontName: KDWPTH+Shaker2Lancet-Regular
       Flags: Nonsymbolic
       FontBBox: -158, -241, 1019, 980
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: OJKNXZ+Shaker2Lancet-Bold
      FontSubset: true
      FirstChar: 32
      LastChar: 117
      FontDescriptor: 
       FontName: OJKNXZ+Shaker2Lancet-Bold
       Flags: Nonsymbolic
       FontBBox: -164, -241, 1109, 981
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: KDWPTH+Shaker2Lancet-BoldItalic
      FontSubset: true
      FirstChar: 28
      LastChar: 117
      FontDescriptor: 
       FontName: KDWPTH+Shaker2Lancet-BoldItalic
       Flags: Nonsymbolic, Italic
       FontBBox: -185, -241, 1072, 981
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
   XMP: <x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 4.0-c316 44.253921, Sun Oct 01 2006 17:14:39">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:dc="http://purl.org/dc/elements/1.1/">
         <dc:format>application/pdf</dc:format>
         <dc:identifier>doi:10.1016/S1470-2045(19)30215-3</dc:identifier>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial</rdf:li>
            </rdf:Alt>
         </dc:title>
         <dc:creator>
            <rdf:Seq>
               <rdf:li>Prof Ian Judson MD</rdf:li>
               <rdf:li>James P Morden MSc</rdf:li>
               <rdf:li>Lucy Kilburn MSc</rdf:li>
               <rdf:li>Michael Leahy FRCP</rdf:li>
               <rdf:li>Charlotte Benson MBChB</rdf:li>
               <rdf:li>Vivek Bhadri MBBS</rdf:li>
               <rdf:li>Quentin Campbell-Hewson MBChB</rdf:li>
               <rdf:li>Ricardo Cubedo PhD</rdf:li>
               <rdf:li>Adam Dangoor MD</rdf:li>
               <rdf:li>Lisa Fox PhD</rdf:li>
               <rdf:li>Ivo Hennig MD</rdf:li>
               <rdf:li>Katy Jarman BSc</rdf:li>
               <rdf:li>Warren Joubert FRACP</rdf:li>
               <rdf:li>Sarah Kernaghan BSc</rdf:li>
               <rdf:li>Antonio López Pousa MD</rdf:li>
               <rdf:li>Catriona McNeil PhD</rdf:li>
               <rdf:li>Beatrice Seddon PhD</rdf:li>
               <rdf:li>Claire Snowdon MSc</rdf:li>
               <rdf:li>Prof Martin Tattersall MD</rdf:li>
               <rdf:li>Christy Toms DPhil</rdf:li>
               <rdf:li>Javier Martinez Trufero MD</rdf:li>
               <rdf:li>Prof Judith M Bliss MSc</rdf:li>
            </rdf:Seq>
         </dc:creator>
         <dc:subject>
            <rdf:Bag/>
         </dc:subject>
         <dc:description>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Lancet Oncology, 20 (2019) 1023-1034. doi:10.1016/S1470-2045(19)30215-3</rdf:li>
            </rdf:Alt>
         </dc:description>
         <dc:publisher>
            <rdf:Bag>
               <rdf:li>The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license</rdf:li>
            </rdf:Bag>
         </dc:publisher>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:prism="http://prismstandard.org/namespaces/basic/3.0/">
         <prism:aggregationType>journal</prism:aggregationType>
         <prism:publicationName>Lancet Oncology</prism:publicationName>
         <prism:copyright>Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. All rights reserved.</prism:copyright>
         <prism:issn>1470-2045</prism:issn>
         <prism:volume>20</prism:volume>
         <prism:number>7</prism:number>
         <prism:pageRange>1023-1034</prism:pageRange>
         <prism:startingPage>1023</prism:startingPage>
         <prism:endingPage>1034</prism:endingPage>
         <prism:doi>10.1016/S1470-2045(19)30215-3</prism:doi>
         <prism:url>http://dx.doi.org/10.1016/S1470-2045(19)30215-3</prism:url>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:crossmark="http://crossref.org/crossmark/1.0/">
         <crossmark:MajorVersionDate>2010-04-23</crossmark:MajorVersionDate>
         <crossmark:CrossmarkDomainExclusive>true</crossmark:CrossmarkDomainExclusive>
         <crossmark:DOI>10.1016/S1470-2045(19)30215-3</crossmark:DOI>
         <crossmark:CrossMarkDomains>
            <rdf:Seq>
               <rdf:li>elsevier.com</rdf:li>
               <rdf:li>sciencedirect.com</rdf:li>
            </rdf:Seq>
         </crossmark:CrossMarkDomains>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:jav="http://www.niso.org/schemas/jav/1.0/">
         <jav:journal_article_version>VoR</jav:journal_article_version>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:pdfx="http://ns.adobe.com/pdfx/1.3/">
         <pdfx:ElsevierWebPDFSpecifications>6.5</pdfx:ElsevierWebPDFSpecifications>
         <pdfx:doi>10.1016/S1470-2045(19)30215-3</pdfx:doi>
         <pdfx:robots>noindex</pdfx:robots>
         <pdfx:CrossmarkMajorVersionDate>2010-04-23</pdfx:CrossmarkMajorVersionDate>
         <pdfx:CrossmarkDomainExclusive>true</pdfx:CrossmarkDomainExclusive>
         <pdfx:CrossMarkDomains>
            <rdf:Seq>
               <rdf:li>sciencedirect.com</rdf:li>
               <rdf:li>elsevier.com</rdf:li>
            </rdf:Seq>
         </pdfx:CrossMarkDomains>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xap="http://ns.adobe.com/xap/1.0/">
         <xap:CreatorTool>Elsevier</xap:CreatorTool>
         <xap:CreateDate>2019-06-22T04:44:17+05:30</xap:CreateDate>
         <xap:ModifyDate>2019-06-29T13:19:10+05:30</xap:ModifyDate>
         <xap:MetadataDate>2019-06-29T13:19:10+05:30</xap:MetadataDate>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xapRights="http://ns.adobe.com/xap/1.0/rights/">
         <xapRights:Marked>True</xapRights:Marked>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/">
         <pdf:Keywords/>
         <pdf:Producer>Acrobat Distiller 6.0 for Windows</pdf:Producer>
         <pdf:Trapped>False</pdf:Trapped>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xapMM="http://ns.adobe.com/xap/1.0/mm/">
         <xapMM:DocumentID>uuid:0c493aba-57a2-481e-af51-4371cca780e3</xapMM:DocumentID>
         <xapMM:InstanceID>uuid:9fc91392-4503-4a0c-b5a0-5f6a54c5a33f</xapMM:InstanceID>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
   Pages: 
    Page: 
     Label: 1023
     Sequence: 1
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 522, 654, 545, 680
    Page: 
     Label: 1024
     Sequence: 2
    Page: 
     Label: 1025
     Sequence: 3
    Page: 
     Label: 1026
     Sequence: 4
    Page: 
     Label: 1027
     Sequence: 5
    Page: 
     Label: 1028
     Sequence: 6
    Page: 
     Label: 1029
     Sequence: 7
    Page: 
     Label: 1030
     Sequence: 8
    Page: 
     Label: 1031
     Sequence: 9
    Page: 
     Label: 1032
     Sequence: 10
    Page: 
     Label: 1033
     Sequence: 11
    Page: 
     Label: 1034
     Sequence: 12
  Checksum: 82152d00
   Type: CRC32
  Checksum: 7e8fc4446a17ab0f23008c2161c996a7
   Type: MD5
  Checksum: 9b96b855ae670b3217d8a0fef9e0afb5f53d91d7
   Type: SHA-1
  Checksum: ed77a8aa9edda1f567029f7b8eb4d7d323f0e8451f983bfafc04047a9d8db80b
   Type: SHA-256